(2023)
The role of subspecialized radiologist reviews in preoperative conference for hepato-pancreato-biliary disease.
EUROPEAN JOURNAL OF RADIOLOGY.
169,
(2023)
Comprehensive immunoprofile analysis of prognostic markers in pancreaticobiliary tract cancers.
CANCER MEDICINE.
12,
7
(2023)
Use of individualized 3D-printed models of pancreatic cancer to improve surgeons’ anatomic understanding and surgical planning.
EUROPEAN RADIOLOGY.
33,
11
(2022)
Total Bilirubin Level as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer.
KOREAN JOURNAL OF RADIOLOGY.
23,
4
(2021)
Prognostic value of LI-RADS category on gadoxetic acid-enhanced MRI and 18F-FDG PET-CT in patients with primary liver carcinomas.
EUROPEAN RADIOLOGY.
31,
6
(2021)
Vanishing washout of hepatocellular carcinoma according to the presence of hepatic steatosis: diagnostic performance of CT and MRI.
EUROPEAN RADIOLOGY.
31,
5
(2021)
A comparative study of survivor outcomes between preoperative evaluation using ct alone and combined CT and MRI in patients with pancreatic ductal adenocarcinoma.
대한영상의학회지.
82,
3
(2021)
Comparison of Super-Resolution US and Contrast Material-enhanced US in Detection of the Spoke Wheel Sign in Patients with Focal Nodular Hyperplasia.
RADIOLOGY.
298,
1
(2021)
Gadoxetic acid-enhanced MRI for differentiating hepatic sclerosing hemangioma from malignant tumor.
EUROPEAN JOURNAL OF RADIOLOGY.
135,
(2021)
Radiologic Evaluation and Structured Reporting Form for Extrahepatic Bile Duct Cancer: 2019 Consensus Recommendations from the Korean Society of Abdominal Radiology.
KOREAN JOURNAL OF RADIOLOGY.
22,
1
(2020)
Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients.
KOREAN JOURNAL OF RADIOLOGY.
21,
4
(2020)
Use of Gadoxetic Acid enhanced Liver MRI and Morality in More than 30000 Patients with Hepatocellular Carcinoma: A Nationwide Analysis.
RADIOLOGY.
295,
1
(2020)
Value of Gadoxetic Acid-Enhanced MRI and Diffusion-Weighted Imaging in the Differentiation of Hypervascular Hyperplastic Nodule From Small (< 3 cm) Hypervascular Hepatocellular Carcinoma in Patients With Alcoholic Liver Cirrhosis: A Retrospective Case-Control Study.
JOURNAL OF MAGNETIC RESONANCE IMAGING.
51,
1
(2019)
Differentiation of Hepatic Sclerosed Hemangiomas From Cavernous Hemangiomas Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Features.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY.
43,
5
(2019)
Differences in early imaging features and pattern of progression on CT between intrahepatic biliary metastasis of colorectal origin and intrahepatic non-mass-forming cholangiocarcinoma in patients with extrabiliary malignancy.
ABDOMINAL RADIOLOGY.
44,
4
(2019)
Identification of Arterial Hyperenhancement in CT and MRI in Patients with Hepatocellular Carcinoma: Value of Unenhanced Images.
KOREAN JOURNAL OF RADIOLOGY.
20,
2
(2019)
Pre-operative ADC predicts early recurrence of HCC after curative resection.
EUROPEAN RADIOLOGY.
29,
2
(2019)
Apparent diffusion coefficient as a potential marker for tumour differentiation, staging and long-term clinical outcomes in gallbladder cancer.
EUROPEAN RADIOLOGY.
29,
1
(2019)
Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients.
PLOS ONE.
14,
1
(2018)
Hepatic neuroendocrine tumors: gadoxetic acid-enhanced magnetic resonance imaging findings with an emphasis on differentiation between primary and secondary tumors.
ABDOMINAL RADIOLOGY.
43,
12
Conference Paper
(2020)
A comparative study of survivor outcomes between preoperative evaluation using CT alone and combined CT and MRI in pancreas ductal adenocarcinoma patients.
KCR 2020.
KOREA, REPUBLIC OF
(2020)
Detection of locally recurrent pancreatic cancer after surgical resection: added value of diffusion-weighted MRI.
KCR 2020.
KOREA, REPUBLIC OF
(2020)
Differentiating hepatocellular adenoma from hepatocellular carcinoma in normal liver on gadoxetic acid-enhanced and diffusion-weighted MR imaging.
KCR 2020.
KOREA, REPUBLIC OF
(2020)
Hepatic tumors.
KCR 좌장.
KOREA, REPUBLIC OF
(2019)
Neoplastic Diseases of the Bile Duct.
대한복부영상의학회 연수교육- 췌담도질환.
KOREA, REPUBLIC OF
(2019)
Challenging cases of pancreatic adenocarcinoma.
KSAR/SIAD meeting.
FRANCE
(2019)
삼성간암센터 심포지움 Panel discussion.
제2회 삼성서울병원 간암센터 심포지움.
KOREA, REPUBLIC OF
(2019)
The Role of EOB-MRI for HCC Diagnosis and Predicting Prognosis.
ICMRI 2019.
KOREA, REPUBLIC OF
(2018)
Imaging biomarkers in predicting biologic behavior and prognosis.
1st SMC Liver Cancer Center Symposium.
KOREA, REPUBLIC OF
(2018)
Radiological cases (Metatases).
APLIS 2018.
CHINA
(2018)
Multidisciplinary Approach for biliary Disease: Role of Imaging.
GE Academy 2018.
KOREA, REPUBLIC OF
(2018)
Informal Scientific Presentation.
KCR 2018.
KOREA, REPUBLIC OF
(2018)
Prediction of HCC invasiveness.
KCR 2018.
KOREA, REPUBLIC OF
(2018)
Biomarkers representing aggressiveness of HCCs.
제11회 대한ITA영상의학회 정기학술대회.
KOREA, REPUBLIC OF
(2018)
Single Hepatocellular Carcinoma: Preoperative Diffusion-weighted MRI for Predicting Early Recurrence after Curative Resection.
APPLE 2018.
KOREA, REPUBLIC OF
(2018)
Tumor Biology, 치료 전 Non-Invasive 하게 예측할 수 있을까?.
제1회 간암스쿨.
KOREA, REPUBLIC OF
(2018)
Beyond the Degraded Arterial Image.
The 8th Liver Imaging Day.
KOREA, REPUBLIC OF
(2017)
Differentiating metastatic mucinous adenocarcinoma from simple cyst of the liver: the value of gadoxetic acid-enhanced and diffusion-weighted MR imaging.
KCR 2017.
KOREA, REPUBLIC OF
(2017)
The value of gadoxetic acid-enhanced and diffusion-weighted MR imaging for differentiating hepatocellular adenoma from hepatocellular carcinoma.
KCR 2017.
KOREA, REPUBLIC OF
(2017)
Pancreatic adenocarcinoma: preoperative imaging biomarker for predicting prognosis after curative resection.
ESGAR 2017.
GREECE